Metabolic signature of eyelid basal cell carcinoma.

In conclusion, eyelid BCC has a signature change of cell metabolome. Metabolites in NAD metabolic pathways could potentially be biomarkers or therapeutic targets for eyelid BCC.
PMID: 32649951 [PubMed - as supplied by publisher]

Source: Experimental Eye Research - July 6, 2020 Category: Opthalmology Authors: Huang J, Schaefer J, Wang Y, Gioia L, Pei Y, Shi X, Waris S, Zhao C, Nguyen J, Du J Tags: Exp Eye Res Source Type: research